Learning objectives
After watching this webinar, participants will understand:
Needs assessment and expected educational outcome
To delve into the evidence behind the main changes in the 2023 ESC Guidelines for Management of Cardiomyopathies and to understand how they impact clinical practice.
This programme is supported by Bristol-Myers Squibb in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main topic:
Related topics:
For a complete overview on the 2023 ESC Guidelines for the management of cardiomyopathies please visit the FOCUS edition webpage dedicated to this particular topic.
Session information
This webinar is designed for general practitioners, primary care doctors and general cardiologist but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).